Replies to post #242339 on Biotech Values

[Whalatane]

Dew. AMRN has 10 yrs exclusivity in the UK / EU based on their Reduce It trial .
But they are burning cash and losing market share here in the US, while reimbursement negotiations drag on in the UK / EU

Not a great day to have positions in AMRN or KZR :--(

Kiwi